Dave Muoio

By Dave Muoio 04:08 pmJuly 29, 2019
Direct-to-consumer telemedicine services have attracted plenty of attention from investors and patients alike, due in part to their lower costs and ease of use. From a medical standpoint, however, these business models introduce a number of departures from traditional care that deserve serious concern and investigation, argue the authors of an editorial published Friday in JAMA. “DTC telemedicine...
By Dave Muoio 11:47 amJuly 29, 2019
Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the platform, called Eko Home, as a resource for clinical trials targeting new therapies. The new platform is already seeing some action. According to the company, an ongoing Mayo Clinic study exploring...
By Dave Muoio 02:32 pmJuly 26, 2019
In many respects, the pharma industry’s operations are still in the early stages of technological  revolution, and there’s no better example of this than its gradual adoption of digital health and digital therapeutics. On one hand, more and more groups are regularly striking new partnerships that supplement existing drug treatments with digital tools, while Novartis continues its work with Pear...
By Dave Muoio 03:58 pmJuly 25, 2019
IPO fever is hitting a bit of a frenzy amidst a slew of recent listings, and with it has come a renewed focus on the exact boundaries of digital health — or, alternately, of health-tech, connected health, eHealth, or any of the other myriad monikers for the intersections of healthcare, technology and innovation. As observers from various mainstream and niche industries have flocked to discuss ...
By Dave Muoio 01:33 pmJuly 25, 2019
After months of treading water, mobile ECG maker AliveCor has finally named its new CEO: Priya Abani, who up until this point led the Alexa Voice Service for Amazon. Abani’s three years at Amazon as general manager for devices and enablement saw her spearheading integration efforts to integrate voice assistant with Amazon’s various connected services, as well as leading its product, engineering,...
By Dave Muoio 02:53 pmJuly 24, 2019
This morning CVS Health and its recently acquired Aetna business announced new initiatives that will work with community organizers, social services and software makers to tackle social and environmental factors affecting individuals’ health. To do so, the company has partnered with Unite Us, maker of care coordination products specifically designed to drive connections between social services...
By Dave Muoio 11:16 amJuly 24, 2019
Tivic Health Systems, maker of a commercial sinus pain relief device, announced yesterday that it has raised $8 million in seed funding. Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, an unnamed physician network and individual investors each backed the company through a series of smaller investments, the most recent of which the...
By Dave Muoio 03:42 pmJuly 23, 2019
Flare Capital Partners has closed a second health tech investment fund totaling $255 million, a $55 million bump over its original target of $200 million due to interest from new strategic and financial investors, the venture capital firm announced today. “The logic for the size of the fund was really important,” Michael Greeley, general partner at Flare Capital Partners, told MobiHealthNews. “We...
By Dave Muoio 01:38 pmJuly 23, 2019
Roughly a year after its launch, Walgreens Boots Alliance announced that its Find Care platform — a mobile and web tool guiding consumers toward curated health services — has added eight new partners including Propeller Health, Dexcom and a handful of regional health systems. The two digital companies’ connected inhaler sensors and CGM devices add new chronic care management options to the retail...
By Dave Muoio 03:59 pmJuly 22, 2019
Prescription digital therapeutics company Pear Therapeutics announced late last week that it has filed an FDA marketing authorization for Somryst, its digital cognitive behavioral therapy for the treatment of adults with chronic insomnia and depression. While an approval from the agency would mark the third authorized prescription digital therapeutic for Pear — behind reSET for substance use...